First Time Loading...
B

BioLine RX Ltd
TASE:BLRX

Watchlist Manager
BioLine RX Ltd
TASE:BLRX
Watchlist
Price: 18.1 ILS 5.23%
Updated: May 29, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

63.9m
+21%
Assets
Growth Rates:
1 Year
-16%
3 Years
+35%
5 Years
+14%
7 Years
+64%
10 Years
+219%
50.7m
+28%
Liabilities
Growth Rates:
1 Year
+98%
3 Years
+101%
5 Years
+240%
7 Years
+1 197%
10 Years
+511%
13.2m
+0.7%
Equity
Growth Rates:
1 Year
-74%
3 Years
-40%
5 Years
-68%
7 Years
-62%
10 Years
+13%

Balance Sheet Decomposition
BioLine RX Ltd

63.9m
Assets
50.7m
Liabilities
63.9m
Assets
50.7m
Liabilities
Current Assets 47.2m
Cash & Short-Term Investments 43m
Receivables 1.2m
Other Current Assets 3m
Non-Current Assets 16.7m
PP&E 1.9m
Intangibles 14.9m
Current Liabilities 30.9m
Accounts Payable 14.2m
Other Current Liabilities 16.6m
Non-Current Liabilities 19.9m
Long-Term Debt 7.9m
Other Non-Current Liabilities 11.9m

Balance Sheet
BioLine RX Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
1
1
4
2
5
17
8
4
3
Cash
2
1
1
4
2
0
0
8
4
3
Cash Equivalents
0
0
0
0
0
5
17
0
0
0
Short-Term Investments
32
47
35
46
28
22
6
49
47
40
Total Receivables
0
0
0
1
1
1
0
0
1
1
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
1
Inventory
0
0
0
0
0
0
0
0
0
2
Other Current Assets
0
0
0
0
0
0
0
0
0
1
Total Current Assets
35
48
36
50
32
28
23
57
52
47
PP&E Net
1
3
3
3
2
3
3
2
2
2
PP&E Gross
1
3
3
3
2
0
0
2
2
2
Accumulated Depreciation
1
1
1
2
2
0
0
5
5
6
Intangible Assets
0
0
0
7
22
22
22
22
22
15
Long-Term Investments
0
0
0
1
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
36
N/A
51
+42%
39
-24%
61
+57%
56
-8%
54
-5%
47
-12%
81
+72%
76
-6%
64
-16%
Liabilities
Accounts Payable
2
2
3
6
4
9
7
6
7
11
Accrued Liabilities
1
1
1
1
1
0
0
1
2
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
1
3
3
3
2
4
Other Current Liabilities
0
0
0
0
0
0
0
0
0
13
Total Current Liabilities
3
3
4
7
7
12
11
10
11
31
Long-Term Debt
0
0
0
0
8
8
4
2
10
8
Other Liabilities
2
0
0
1
0
1
10
2
5
12
Total Liabilities
4
N/A
4
-16%
4
+6%
8
+107%
15
+84%
20
+35%
25
+25%
13
-47%
26
+92%
51
+98%
Equity
Common Stock
1
1
2
3
3
5
10
21
27
31
Retained Earnings
135
149
165
189
211
236
266
291
314
372
Additional Paid In Capital
167
196
200
241
250
266
279
339
339
355
Other Equity
1
1
1
1
1
1
1
1
1
1
Total Equity
32
N/A
48
+50%
35
-26%
53
+51%
41
-22%
33
-19%
22
-34%
68
+209%
51
-25%
13
-74%
Total Liabilities & Equity
36
N/A
51
+42%
39
-24%
61
+57%
56
-8%
54
-5%
47
-12%
81
+72%
76
-6%
64
-16%
Shares Outstanding
Common Shares Outstanding
39
55
57
105
115
171
349
715
923
1 087

See Also

Summary
BLRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLRX stock valuation using valuation multiples.
Wall Street Estimates
BLRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.